1-20 of 79
glyburide
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Factors Associated With Hypoglycemia Among Neonates Born to Mothers With Gestational Diabetes Mellitus

Martha B. Kole, Nina K. Ayala, Melissa A. Clark, Phinnara Has, Mathew Esposito, Erika F. Werner
Journal: Diabetes Care
Diabetes Care 2020;43(12):e194–e195
https://doi.org/10.2337/dc20-1261
Published: 13 October 2020
View article titled, Factors Associated With Hypoglycemia Among Neonates Born to Mothers With Gestational Diabetes Mellitus
Open the PDF for Factors Associated With Hypoglycemia Among Neonates Born to Mothers With Gestational Diabetes Mellitus in another window
Journal Articles

Comparative Safety of Sulfonylureas and the Risk of Sudden Cardiac Arrest and Ventricular Arrhythmia

Charles E. Leonard, Colleen M. Brensinger, Christina L. Aquilante, Warren B. Bilker, Denise M. Boudreau, Rajat Deo, James H. Flory, Joshua J. Gagne, Margaret J. Mangaali, Sean Hennessy
Journal: Diabetes Care
Diabetes Care 2018;41(4):713–722
https://doi.org/10.2337/dc17-0294
Published: 02 February 2018
View article titled, Comparative Safety of Sulfonylureas and the Risk of Sudden Cardiac Arrest and Ventricular Arrhythmia
Open the PDF for Comparative Safety of Sulfonylureas and the Risk of Sudden Cardiac Arrest and Ventricular Arrhythmia in another window
Includes: Supplementary data
Journal Articles

Pharmacologic Differences of Sulfonylureas and the Risk of Adverse Cardiovascular and Hypoglycemic Events

Antonios Douros, Hui Yin, Oriana Hoi Yun Yu, Kristian B. Filion, Laurent Azoulay, Samy Suissa
Journal: Diabetes Care
Diabetes Care 2017;40(11):1506–1513
https://doi.org/10.2337/dc17-0595
Published: 01 September 2017
View article titled, Pharmacologic Differences of Sulfonylureas and the Risk of Adverse Cardiovascular and Hypoglycemic Events
Open the PDF for Pharmacologic Differences of Sulfonylureas and the Risk of Adverse Cardiovascular and Hypoglycemic Events in another window
Includes: Supplementary data
Journal Articles

Comment on Nachum et al. Glyburide Versus Metformin and Their Combination for the Treatment of Gestational Diabetes Mellitus: A Randomized Controlled Study. Diabetes Care 2017;40:332–337

Linda A. Barbour, Jill K. Davies
Journal: Diabetes Care
Diabetes Care 2017;40(8):e115
https://doi.org/10.2337/dc17-0554
Published: 11 July 2017
View article titled, Comment on Nachum et al. Glyburide Versus Metformin and Their Combination for the Treatment of Gestational Diabetes Mellitus: A Randomized Controlled Study. Diabetes Care 2017;40:332–337
Open the PDF for Comment on Nachum et al. Glyburide Versus Metformin and Their Combination for the Treatment of Gestational Diabetes Mellitus: A Randomized Controlled Study. Diabetes Care 2017;40:332–337 in another window
Journal Articles

Response to Comment on Nachum et al. Glyburide Versus Metformin and Their Combination for the Treatment of Gestational Diabetes Mellitus: A Randomized Controlled Study. Diabetes Care 2017;40:332–337

Zohar Nachum, Enav Yefet
Journal: Diabetes Care
Diabetes Care 2017;40(8):e116
https://doi.org/10.2337/dci17-0016
Published: 11 July 2017
View article titled, Response to Comment on Nachum et al. Glyburide Versus Metformin and Their Combination for the Treatment of Gestational Diabetes Mellitus: A Randomized Controlled Study. Diabetes Care 2017;40:332–337
Open the PDF for Response to Comment on Nachum et al. Glyburide Versus Metformin and Their Combination for the Treatment of Gestational Diabetes Mellitus: A Randomized Controlled Study. Diabetes Care 2017;40:332–337 in another window
Journal Articles

Glyburide Versus Metformin and Their Combination for the Treatment of Gestational Diabetes Mellitus: A Randomized Controlled Study

Zohar Nachum, Noah Zafran, Raed Salim, Noura Hissin, Jamal Hasanein, Yifat Gam Ze Letova, Abeer Suleiman, Enav Yefet
Journal: Diabetes Care
Diabetes Care 2017;40(3):332–337
https://doi.org/10.2337/dc16-2307
Published: 11 January 2017
View article titled, Glyburide Versus Metformin and Their Combination for the Treatment of Gestational Diabetes Mellitus: A Randomized Controlled Study
Open the PDF for Glyburide Versus Metformin and Their Combination for the Treatment of Gestational Diabetes Mellitus: A Randomized Controlled Study in another window
Journal Articles

The Use of Glyburide Compared With Other Sulfonylureas and the Risk of Cancer in Patients With Type 2 Diabetes

Marco Tuccori, Jennifer W. Wu, Hui Yin, Agnieszka Majdan, Laurent Azoulay
Journal: Diabetes Care
Diabetes Care 2015;38(11):2083–2089
https://doi.org/10.2337/dc15-1358
Published: 04 September 2015
View article titled, The Use of Glyburide Compared With Other Sulfonylureas and the Risk of Cancer in Patients With Type 2 Diabetes
Open the PDF for The Use of Glyburide Compared With Other Sulfonylureas and the Risk of Cancer in Patients With Type 2 Diabetes in another window
Includes: Supplementary data
Journal Articles

Remission of Severe Neonatal Diabetes With Very Early Sulfonylurea Treatment

Bess A. Marshall, Rebecca P. Green, Jennifer Wambach, Neil H. White, Maria S. Remedi, Colin G. Nichols
Journal: Diabetes Care
Diabetes Care 2015;38(3):e38–e39
https://doi.org/10.2337/dc14-2124
Published: 12 February 2015
View article titled, Remission of Severe Neonatal Diabetes With Very Early Sulfonylurea Treatment
Open the PDF for Remission of Severe Neonatal Diabetes With Very Early Sulfonylurea Treatment in another window
Journal Articles

Fetal Macrosomia and Neonatal Hyperinsulinemic Hypoglycemia Associated With Transplacental Transfer of Sulfonylurea in a Mother With KCNJ11-Related Neonatal Diabetes

Nele Myngheer, Karel Allegaert, Andrew Hattersley, Tim McDonald, Holger Kramer, Frances M. Ashcroft, Johan Verhaeghe, Chantal Mathieu, Kristina Casteels
Journal: Diabetes Care
Diabetes Care 2014;37(12):3333–3335
https://doi.org/10.2337/dc14-1247
Published: 08 November 2014
View article titled, Fetal Macrosomia and Neonatal Hyperinsulinemic Hypoglycemia Associated With Transplacental Transfer of Sulfonylurea in a Mother With <em>KCNJ11</em>-Related Neonatal Diabetes
Open the PDF for Fetal Macrosomia and Neonatal Hyperinsulinemic Hypoglycemia Associated With Transplacental Transfer of Sulfonylurea in a Mother With <em>KCNJ11</em>-Related Neonatal Diabetes in another window
Journal Articles

Patient With iDEND Syndrome–Related Mutation

Ana M. Prado-Carro, Joan Calzada-Hernández, Silvia Marín, Roque Cardona-Hernandez, Josep Oriola, Marta Nicolás, Marta Ramon-Krauel
Journal: Diabetes Care
Diabetes Care 2014;37(6):e123–e124
https://doi.org/10.2337/dc13-2877
Published: 10 May 2014
View article titled, Patient With iDEND Syndrome–Related Mutation
Open the PDF for Patient With iDEND Syndrome–Related Mutation in another window
Journal Articles

Long-Term Efficacy of Glibenclamide and Sitagliptin Therapy in Adult Patients With KCNJ11 Permanent Diabetes

Julia Sastre, Alessandra Luque, Florentino del Val, Angel Aragonés, José López
Journal: Diabetes Care
Diabetes Care 2014;37(3):e55–e56
https://doi.org/10.2337/dc13-2280
Published: 11 February 2014
View article titled, Long-Term Efficacy of Glibenclamide and Sitagliptin Therapy in Adult Patients With KCNJ11 Permanent Diabetes
Open the PDF for Long-Term Efficacy of Glibenclamide and Sitagliptin Therapy in Adult Patients With KCNJ11 Permanent Diabetes in another window
Journal Articles

Comment on: Harrison et al. β -Cell Function Preservation After 3.5 Years of Intensive Diabetes Therapy. Diabetes Care 2012;35:1406–1412

Toru Aizawa, MD, PHD, Keishi Yamauchi, MD, PHD
Journal: Diabetes Care
Diabetes Care 2013;36(1):e16
https://doi.org/10.2337/dc12-1419
Published: 11 December 2012
View article titled, Comment on: Harrison et al. β -Cell Function Preservation After 3.5 Years of Intensive Diabetes Therapy. Diabetes Care 2012;35:1406–1412
Open the PDF for Comment on: Harrison et al. β -Cell Function Preservation After 3.5 Years of Intensive Diabetes Therapy. Diabetes Care 2012;35:1406–1412 in another window
Journal Articles

β-Cell Function Preservation After 3.5 Years of Intensive Diabetes Therapy

Lindsay B. Harrison, MD, Beverley Adams-Huet, MS, Philip Raskin, MD, Ildiko Lingvay, MD
Journal: Diabetes Care
Diabetes Care 2012;35(7):1406–1412
https://doi.org/10.2337/dc11-2170
Published: 12 June 2012
View article titled, β-Cell Function Preservation After 3.5 Years of Intensive Diabetes Therapy
Open the PDF for β-Cell Function Preservation After 3.5 Years of Intensive Diabetes Therapy in another window
Includes: Supplementary data
Journal Articles

Rosiglitazone-Associated Fractures in Type 2 Diabetes: An analysis from A Diabetes Outcome Progression Trial (ADOPT)

Steven E. Kahn, MB, CHB, Bernard Zinman, MD, John M. Lachin, SCD, Steven M. Haffner, MD, William H. Herman, MD, Rury R. Holman, MD, Barbara G. Kravitz, MS, Dahong Yu, PHD, Mark A. Heise, PHD, R. Paul Aftring, MD, PHD, Giancarlo Viberti, MD, for the A Diabetes Outcome Progression Trial (ADOPT) Study Group
Journal: Diabetes Care
Diabetes Care 2008;31(5):845–851
https://doi.org/10.2337/dc07-2270
Published: 01 May 2008
View article titled, Rosiglitazone-Associated Fractures in Type 2 Diabetes: <subtitle>An analysis from A Diabetes Outcome Progression Trial (ADOPT)</subtitle>
Open the PDF for Rosiglitazone-Associated Fractures in Type 2 Diabetes: <subtitle>An analysis from A Diabetes Outcome Progression Trial (ADOPT)</subtitle> in another window
Includes: Supplementary data
Journal Articles

Sulfonylrea Treatment in Permanent Neonatal Diabetes Due to G53D Mutation in the KCNJ11 Gene: Improvement in glycemic control and neurological function

Lucimary C. Gurgel, MD, Felipe Crispim, BSC, Maria Helena S. Noffs, MSC, Erich Belzunces, BSC, Marcio A. Rahal, MD, Regina S. Moisés, MD, PHD
Journal: Diabetes Care
Diabetes Care 2007;30(11):e108
https://doi.org/10.2337/dc07-1196
Published: 01 November 2007
View article titled, Sulfonylrea Treatment in Permanent Neonatal Diabetes Due to G53D Mutation in the <em>KCNJ11</em> Gene: <subtitle>Improvement in glycemic control and neurological function</subtitle>
Open the PDF for Sulfonylrea Treatment in Permanent Neonatal Diabetes Due to G53D Mutation in the <em>KCNJ11</em> Gene: <subtitle>Improvement in glycemic control and neurological function</subtitle> in another window
Journal Articles

Counterpoint: Oral Hypoglyemic Agents Should Be Used to Treat Diabetic Pregnant Women

Edward J. Coetzee
Journal: Diabetes Care
Diabetes Care 2007;30(11):2980–2982
https://doi.org/10.2337/dc07-1620
Published: 01 November 2007
View article titled, Counterpoint: Oral Hypoglyemic Agents Should Be Used to Treat Diabetic Pregnant Women
Open the PDF for Counterpoint: Oral Hypoglyemic Agents Should Be Used to Treat Diabetic Pregnant Women in another window
Journal Articles

Early Glibenclamide Treatment in a Clinical Newborn With KCNJ11 Gene Mutation

Gerhard Däublin, MD, Bettina Lorenz-Depiereux, PHD, Tim M. Strom, MD, Oliver Blankenstein, MD, Klemens Raile, MD
Journal: Diabetes Care
Diabetes Care 2007;30(10):e104
https://doi.org/10.2337/dc07-1318
Published: 01 October 2007
View article titled, Early Glibenclamide Treatment in a Clinical Newborn With <em>KCNJ11</em> Gene Mutation
Open the PDF for Early Glibenclamide Treatment in a Clinical Newborn With <em>KCNJ11</em> Gene Mutation in another window
Journal Articles

Pharmacological Management of Gestational Diabetes: An overview

Donald R. Coustan, MD
Journal: Diabetes Care
Diabetes Care 2007;30(Supplement_2):S206–S208
https://doi.org/10.2337/dc07-s217
Published: 01 July 2007
View article titled, Pharmacological Management of Gestational Diabetes: <subtitle>An overview</subtitle>
Open the PDF for Pharmacological Management of Gestational Diabetes: <subtitle>An overview</subtitle> in another window
Journal Articles

Glyburide for the Treatment of Gestational Diabetes: A critical appraisal

Thomas R. Moore, MD
Journal: Diabetes Care
Diabetes Care 2007;30(Supplement_2):S209–S213
https://doi.org/10.2337/dc07-s218
Published: 01 July 2007
View article titled, Glyburide for the Treatment of Gestational Diabetes: <subtitle>A critical appraisal</subtitle>
Open the PDF for Glyburide for the Treatment of Gestational Diabetes: <subtitle>A critical appraisal</subtitle> in another window
Journal Articles

Counterpoint: A Diabetes Outcome Progression Trial (ADOPT): Good for Sulfonylureas?

Ebaa Al-Ozairi, MD, Latika Sibal, MD, Philip Home, MA, DM, DPHIL
Journal: Diabetes Care
Diabetes Care 2007;30(6):1677–1680
https://doi.org/10.2337/dc07-0339
Published: 01 June 2007
View article titled, Counterpoint: A Diabetes Outcome Progression Trial (ADOPT): Good for Sulfonylureas?
Open the PDF for Counterpoint: A Diabetes Outcome Progression Trial (ADOPT): Good for Sulfonylureas? in another window